Ursonic acid inhibits migration and invasion of human osteosarcoma cells through the suppression of mitogen-activated protein kinases and matrix metalloproteinases
- Authors
- Son, Juhyeon; Cha, Hansol; Lee, Sungeun; Bae, Yongwoong; Ryou, Chongsuk; Lee, Sang Yeol
- Issue Date
- May-2023
- Publisher
- Springer Science and Business Media B.V.
- Keywords
- Matrix metalloproteinase; Metastasis; Mitogen-activated protein kinase; Osteosarcoma; Ursonic acid
- Citation
- Molecular Biology Reports, v.50, no.5, pp 4029 - 4038
- Pages
- 10
- Indexed
- SCIE
SCOPUS
- Journal Title
- Molecular Biology Reports
- Volume
- 50
- Number
- 5
- Start Page
- 4029
- End Page
- 4038
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/112510
- DOI
- 10.1007/s11033-023-08333-4
- ISSN
- 0301-4851
1573-4978
- Abstract
- Introduction: Osteosarcoma (OS) is the most common form of bone malignancy. Although contemporary chemotherapy and surgery have improved the prognosis of those with OS, developing new OS therapies has proven difficult for some time. The activation of the matrix metalloproteinase (MMP) and mitogen-activated protein kinase (MAPK) signaling pathways can induce metastasis, which is an obstacle to OS treatment. Ursonic acid (UNA) is a phytochemical with the potential to cure a variety of human ailments, including cancer. Methods and results: In this study, we investigated the anti-tumor properties of UNA in MG63 cells. We conducted colony formation assay, wound healing assay, and Boyden chamber assays to investigate the anti-OS effects of UNA. UNA was found to significantly inhibit the proliferative, migratory, and invasive abilities of MG63 cells. This bioactivity of UNA was mediated by the inhibition of extracellular signal-regulated kinase (ERK) and p38 and reduction of MMP-2 transcriptional expression as observed in western blot analysis, gelatin zymography and RT-PCR. Anti-OS activities of UNA were also observed in Saos2 and U2OS cells, indicating that its anti-cancer properties are not specific to cell types. Conclusion: Our findings suggest that UNA has the potential for use in anti-metastatic drugs in the treatment of OS. © 2023, The Author(s), under exclusive licence to Springer Nature B.V.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/112510)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.